Page 7 - Aallergic News Today

Swift progress of study enrollment - midpoint of 50 patients reachedInterim analysis confirmed target enrollment of 100 patientsCompletion of enrollment expected by early January 2023HAMILTON, BERMUDA

According to Fortune Business Insights, The Allergic Conjunctivitis Market size is anticipated to reach USD 3.60 Billion by 2028, the market size was USD...

The Singapore Food Agency (SFA) has directed Daiso Singapore to recall H&H Tiramisu Twist cookies due to the presence of undeclared allergens. Read more at stomp.straitstimes.com

Research suggests lizards gain immunity against fire ant venom by eating them, which could also be possible for humans.

All four investigational formulations of OX640 were extensively absorbed and rapidly achieved clinically relevant plasma levels of epinephrine Data available today indicates significantly improved

A boy feigning an allergy to the smell of school books tells his mother it didn’t show up for the first five years of his education because it took that long to ‘incubate’ in a video on social media.

Montrouge, France, September 7, 2022 DBV Technologies Announces Initiation of Phase 3 Study (VITESSE) Using the Modified Viaskin Peanut Patch in Peanut -Allergic Children Ages 4 to 7

Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy (AIT), today announced positive data from its EfficAPSI real-world study. Presented at the 2022 European Academy

Research using Google search inquiries found that latex allergy is the most common allergy in the Philippines.

Since a few years ago, wearing face masks has been a necessity to prevent the spread of COVID, but did you know that it can also be used to mitigate allergies?